Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta‐analysis
Background and Aim We aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends. Methods Studies on epidemiology of primary biliary cholangitis (PBC) in PubMed, Embase, and Cochrane Library were systematically retrieved from inception to...
Uložené v:
| Vydané v: | Journal of gastroenterology and hepatology Ročník 36; číslo 6; s. 1423 - 1434 |
|---|---|
| Hlavní autori: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Australia
Wiley Subscription Services, Inc
01.06.2021
|
| Predmet: | |
| ISSN: | 0815-9319, 1440-1746, 1440-1746 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background and Aim
We aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends.
Methods
Studies on epidemiology of primary biliary cholangitis (PBC) in PubMed, Embase, and Cochrane Library were systematically retrieved from inception to October 2, 2020. Random‐effect model was applied to estimate the pooled PBC incidence and prevalence rates. Subgroup analysis, meta‐regression, and sensitivity analysis were conducted to find out the cause for heterogeneity.
Results
Out of 3974 records identified through database searching, 47 population‐based studies were finally included. The pooled global incidence and prevalence of PBC were 1.76 and 14.60 per 100 000 persons, respectively. Both the PBC incidence and prevalence were lower in the Asia‐Pacific region (0.84, 9.82 per 100 000 persons) than that in North America (2.75, 21.81 per 100 000 persons) and Europe (1.86, 14.59 per 100 000 persons) (P < 0.05). The incidence and prevalence showed an increasing tendency in all three regions, with the fastest growth of prevalence in North America (P < 0.05). We found a similar incidence and a lower prevalence of PBC in Northern Europe than that in Southern Europe. A higher incidence and prevalence were observed in female individuals and in the elderly (60–79).
Conclusion
The PBC incidence and prevalence varied widely across regions, with North America being the highest, followed by Europe, and the lowest in the Asia‐Pacific region. Both the incidence and prevalence showed an increasing tendency worldwide, especially in North America. |
|---|---|
| AbstractList | Background and Aim
We aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends.
Methods
Studies on epidemiology of primary biliary cholangitis (PBC) in PubMed, Embase, and Cochrane Library were systematically retrieved from inception to October 2, 2020. Random‐effect model was applied to estimate the pooled PBC incidence and prevalence rates. Subgroup analysis, meta‐regression, and sensitivity analysis were conducted to find out the cause for heterogeneity.
Results
Out of 3974 records identified through database searching, 47 population‐based studies were finally included. The pooled global incidence and prevalence of PBC were 1.76 and 14.60 per 100 000 persons, respectively. Both the PBC incidence and prevalence were lower in the Asia‐Pacific region (0.84, 9.82 per 100 000 persons) than that in North America (2.75, 21.81 per 100 000 persons) and Europe (1.86, 14.59 per 100 000 persons) (P < 0.05). The incidence and prevalence showed an increasing tendency in all three regions, with the fastest growth of prevalence in North America (P < 0.05). We found a similar incidence and a lower prevalence of PBC in Northern Europe than that in Southern Europe. A higher incidence and prevalence were observed in female individuals and in the elderly (60–79).
Conclusion
The PBC incidence and prevalence varied widely across regions, with North America being the highest, followed by Europe, and the lowest in the Asia‐Pacific region. Both the incidence and prevalence showed an increasing tendency worldwide, especially in North America. We aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends. Studies on epidemiology of primary biliary cholangitis (PBC) in PubMed, Embase, and Cochrane Library were systematically retrieved from inception to October 2, 2020. Random-effect model was applied to estimate the pooled PBC incidence and prevalence rates. Subgroup analysis, meta-regression, and sensitivity analysis were conducted to find out the cause for heterogeneity. Out of 3974 records identified through database searching, 47 population-based studies were finally included. The pooled global incidence and prevalence of PBC were 1.76 and 14.60 per 100 000 persons, respectively. Both the PBC incidence and prevalence were lower in the Asia-Pacific region (0.84, 9.82 per 100 000 persons) than that in North America (2.75, 21.81 per 100 000 persons) and Europe (1.86, 14.59 per 100 000 persons) (P < 0.05). The incidence and prevalence showed an increasing tendency in all three regions, with the fastest growth of prevalence in North America (P < 0.05). We found a similar incidence and a lower prevalence of PBC in Northern Europe than that in Southern Europe. A higher incidence and prevalence were observed in female individuals and in the elderly (60-79). The PBC incidence and prevalence varied widely across regions, with North America being the highest, followed by Europe, and the lowest in the Asia-Pacific region. Both the incidence and prevalence showed an increasing tendency worldwide, especially in North America. We aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends.BACKGROUND AND AIMWe aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends.Studies on epidemiology of primary biliary cholangitis (PBC) in PubMed, Embase, and Cochrane Library were systematically retrieved from inception to October 2, 2020. Random-effect model was applied to estimate the pooled PBC incidence and prevalence rates. Subgroup analysis, meta-regression, and sensitivity analysis were conducted to find out the cause for heterogeneity.METHODSStudies on epidemiology of primary biliary cholangitis (PBC) in PubMed, Embase, and Cochrane Library were systematically retrieved from inception to October 2, 2020. Random-effect model was applied to estimate the pooled PBC incidence and prevalence rates. Subgroup analysis, meta-regression, and sensitivity analysis were conducted to find out the cause for heterogeneity.Out of 3974 records identified through database searching, 47 population-based studies were finally included. The pooled global incidence and prevalence of PBC were 1.76 and 14.60 per 100 000 persons, respectively. Both the PBC incidence and prevalence were lower in the Asia-Pacific region (0.84, 9.82 per 100 000 persons) than that in North America (2.75, 21.81 per 100 000 persons) and Europe (1.86, 14.59 per 100 000 persons) (P < 0.05). The incidence and prevalence showed an increasing tendency in all three regions, with the fastest growth of prevalence in North America (P < 0.05). We found a similar incidence and a lower prevalence of PBC in Northern Europe than that in Southern Europe. A higher incidence and prevalence were observed in female individuals and in the elderly (60-79).RESULTSOut of 3974 records identified through database searching, 47 population-based studies were finally included. The pooled global incidence and prevalence of PBC were 1.76 and 14.60 per 100 000 persons, respectively. Both the PBC incidence and prevalence were lower in the Asia-Pacific region (0.84, 9.82 per 100 000 persons) than that in North America (2.75, 21.81 per 100 000 persons) and Europe (1.86, 14.59 per 100 000 persons) (P < 0.05). The incidence and prevalence showed an increasing tendency in all three regions, with the fastest growth of prevalence in North America (P < 0.05). We found a similar incidence and a lower prevalence of PBC in Northern Europe than that in Southern Europe. A higher incidence and prevalence were observed in female individuals and in the elderly (60-79).The PBC incidence and prevalence varied widely across regions, with North America being the highest, followed by Europe, and the lowest in the Asia-Pacific region. Both the incidence and prevalence showed an increasing tendency worldwide, especially in North America.CONCLUSIONThe PBC incidence and prevalence varied widely across regions, with North America being the highest, followed by Europe, and the lowest in the Asia-Pacific region. Both the incidence and prevalence showed an increasing tendency worldwide, especially in North America. Background and AimWe aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends.MethodsStudies on epidemiology of primary biliary cholangitis (PBC) in PubMed, Embase, and Cochrane Library were systematically retrieved from inception to October 2, 2020. Random‐effect model was applied to estimate the pooled PBC incidence and prevalence rates. Subgroup analysis, meta‐regression, and sensitivity analysis were conducted to find out the cause for heterogeneity.ResultsOut of 3974 records identified through database searching, 47 population‐based studies were finally included. The pooled global incidence and prevalence of PBC were 1.76 and 14.60 per 100 000 persons, respectively. Both the PBC incidence and prevalence were lower in the Asia‐Pacific region (0.84, 9.82 per 100 000 persons) than that in North America (2.75, 21.81 per 100 000 persons) and Europe (1.86, 14.59 per 100 000 persons) (P < 0.05). The incidence and prevalence showed an increasing tendency in all three regions, with the fastest growth of prevalence in North America (P < 0.05). We found a similar incidence and a lower prevalence of PBC in Northern Europe than that in Southern Europe. A higher incidence and prevalence were observed in female individuals and in the elderly (60–79).ConclusionThe PBC incidence and prevalence varied widely across regions, with North America being the highest, followed by Europe, and the lowest in the Asia‐Pacific region. Both the incidence and prevalence showed an increasing tendency worldwide, especially in North America. |
| Author | Jia, Jidong Zhang, Dong Chen, Sha Li, Min Kong, Yuanyuan Lv, Tingting |
| Author_xml | – sequence: 1 givenname: Tingting surname: Lv fullname: Lv, Tingting organization: Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis; National Clinical Research Center for Digestive Disease – sequence: 2 givenname: Sha surname: Chen fullname: Chen, Sha organization: Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis; National Clinical Research Center for Digestive Disease – sequence: 3 givenname: Min surname: Li fullname: Li, Min organization: Capital Medical University – sequence: 4 givenname: Dong surname: Zhang fullname: Zhang, Dong organization: Capital Medical University; Beijing Clinical Research Institute; Beijing Key Laboratory of Tolerance Induction and Organ Protection in Transplantation – sequence: 5 givenname: Yuanyuan surname: Kong fullname: Kong, Yuanyuan email: kongyy@ccmu.edu.cn organization: Capital Medical University – sequence: 6 givenname: Jidong orcidid: 0000-0002-4673-8890 surname: Jia fullname: Jia, Jidong email: jia_jd@ccmu.edu.cn organization: Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis; National Clinical Research Center for Digestive Disease |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33141955$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kctKxDAUhoMoOl4WvoAE3OiimjRJL-4G8YogiK5LJj0dM7TNmHSUuvIRfEafxOPM6ELQbE4SvvOfn_NvktXWtUDILmdHHM_xZPx4xJWI8xUy4FKyiKcyWSUDlnEV5YLnG2QzhAljTLJUrZMNIbjkuVID8noHY-taXdNn7a3u8E51W9IOmqnz-N15wKer6NTbRvuejmxtv6p5dLVux7azgcLUltBYV7txf0KHNPQBBVDNUA_PFl7mmg10-uPtXeO0PtiwTdYqXQfYWdYt8nB-dn96Gd3cXlydDm8igx7zaJQpISCDylRVqVliQEuVZEaOlDQmTphIhc5jk-QxT8s40SoBSLkUKcOmVIstcrDQnXr3NIPQFY0NBmp0D24WiliqNFEilwrR_V_oxM08-kUKCabiTDGk9pbUbNRAWSw3U3xvFYHDBWC8C8FD9YNwVnwlVmBixTwxZI9_scZ28xw6r239X8eLraH_W7q4vrhcdHwC0zmpGw |
| CitedBy_id | crossref_primary_10_3389_fimmu_2023_1124443 crossref_primary_10_1016_j_hbpd_2022_06_014 crossref_primary_10_1097_HEP_0000000000001268 crossref_primary_10_1111_liv_70293 crossref_primary_10_1515_mr_2024_0029 crossref_primary_10_1097_HEP_0000000000001341 crossref_primary_10_1007_s12072_021_10276_6 crossref_primary_10_1093_labmed_lmad018 crossref_primary_10_1097_MS9_0000000000003183 crossref_primary_10_3390_jcm13154497 crossref_primary_10_1016_j_cld_2022_06_001 crossref_primary_10_1016_j_cld_2022_06_004 crossref_primary_10_1007_s12016_025_09074_x crossref_primary_10_1155_2021_9151525 crossref_primary_10_3748_wjg_v28_i31_4417 crossref_primary_10_1007_s12664_024_01610_5 crossref_primary_10_1016_j_aohep_2023_101175 crossref_primary_10_1056_NEJMoa2306185 crossref_primary_10_1097_MD_0000000000038282 crossref_primary_10_1177_1721727X251327293 crossref_primary_10_1038_s41392_024_02072_z crossref_primary_10_1371_journal_pone_0301354 crossref_primary_10_3390_ph18050697 crossref_primary_10_1097_MD_0000000000028987 crossref_primary_10_1002_bcp_70186 crossref_primary_10_1111_hepr_70014 crossref_primary_10_1016_j_ijbiomac_2025_139775 crossref_primary_10_1136_bmjgast_2022_001001 crossref_primary_10_3389_fmolb_2022_915993 crossref_primary_10_3390_biomedicines10082033 crossref_primary_10_1038_s41575_024_00974_5 crossref_primary_10_7759_cureus_36309 crossref_primary_10_3390_ijms26167905 crossref_primary_10_5858_arpa_2024_0057_OA crossref_primary_10_1016_j_livres_2025_01_005 crossref_primary_10_1016_j_aohep_2022_100746 crossref_primary_10_1016_S0140_6736_24_01303_5 crossref_primary_10_4254_wjh_v17_i8_109685 crossref_primary_10_1007_s10654_023_01028_x crossref_primary_10_1016_j_jep_2023_117514 crossref_primary_10_7759_cureus_82008 crossref_primary_10_1080_14740338_2025_2487144 crossref_primary_10_4254_wjh_v17_i7_107666 crossref_primary_10_1111_hepr_13910 crossref_primary_10_2147_HMER_S361077 crossref_primary_10_3389_fimmu_2023_1152294 crossref_primary_10_1097_MS9_0000000000001143 crossref_primary_10_1186_s12876_024_03319_3 crossref_primary_10_3350_cmh_2024_0586 crossref_primary_10_3748_wjg_v29_i29_4580 crossref_primary_10_1177_17562848251370111 crossref_primary_10_3390_cells13181580 crossref_primary_10_1111_1751_2980_13207 crossref_primary_10_1016_j_clinre_2023_102227 crossref_primary_10_3390_tomography11090096 crossref_primary_10_1007_s10620_025_09044_5 crossref_primary_10_1016_j_cgh_2025_03_025 crossref_primary_10_4254_wjh_v17_i6_104073 crossref_primary_10_1111_jgh_70018 crossref_primary_10_1136_gutjnl_2020_322362 crossref_primary_10_1007_s00535_023_01999_4 crossref_primary_10_3390_cancers16162789 crossref_primary_10_1007_s00330_023_10080_w crossref_primary_10_1097_MS9_0000000000002868 crossref_primary_10_1097_HC9_0000000000000179 crossref_primary_10_1016_j_plipres_2024_101291 crossref_primary_10_1016_j_imbio_2023_152398 crossref_primary_10_1136_bmjgast_2023_001287 crossref_primary_10_1007_s12072_021_10267_7 crossref_primary_10_1186_s13075_023_03163_y crossref_primary_10_1111_liv_15267 crossref_primary_10_1016_j_clinre_2025_102598 crossref_primary_10_1097_BOR_0000000000001127 crossref_primary_10_1515_jtim_2025_0034 crossref_primary_10_33590_emjhepatol_TNOM7344 crossref_primary_10_3390_livers5020015 crossref_primary_10_1016_j_dld_2023_02_020 crossref_primary_10_1186_s12876_025_04118_0 crossref_primary_10_1007_s10238_023_01128_8 crossref_primary_10_3389_fped_2023_1280409 crossref_primary_10_3390_biomedicines10102464 crossref_primary_10_3389_fimmu_2023_1184252 crossref_primary_10_3389_fphar_2023_1159222 crossref_primary_10_1016_j_ejim_2024_01_030 crossref_primary_10_1016_j_ejim_2025_07_025 |
| Cites_doi | 10.1016/j.ejim.2012.09.004 10.3121/cmr.2017.1351 10.1053/j.gastro.2004.04.064 10.1111/j.1600-0676.1984.tb00927.x 10.1007/s12072-011-9329-0 10.1111/hepr.13342 10.1136/bmj.326.7382.219 10.1055/s-0034-1383730 10.1038/ctg.2017.43 10.9778/cmajo.20180029 10.1053/jhep.2001.29760 10.1016/j.cld.2018.03.002 10.1038/s41598-019-47890-2 10.1111/apt.13448 10.1002/hep.510240410 10.3109/00365529509093292 10.1007/s12072-019-09984-x 10.1007/s00038-020-01391-6 10.1097/MEG.0b013e328277594a 10.3109/00365528509089711 10.1002/hep.23210 10.3325/cmj.2019.60.494 10.1016/j.jhep.2017.03.022 10.1080/00365520701396034 10.1136/bmj.281.6243.772 10.1002/hep.21076 10.1136/gut.2009.184218 10.1053/gast.2000.20197 10.1080/00365529850166284 10.1016/j.jclinepi.2009.06.006 10.1097/MEG.0b013e328353753d 10.1111/jgh.14521 10.1002/hep.510300213 10.1111/liv.12479 10.1016/S0168-8278(18)30677-9 10.1093/ije/26.4.830 10.1136/gut.36.6.927 10.1002/hep.1840120116 10.1002/hep.20907 10.1016/S1590-8658(12)60110-8 10.1111/j.1572-0241.2002.06019.x 10.1038/srep25906 10.1053/j.gastro.2015.07.061 10.1093/aje/kwt308 10.1002/hep.30145 10.1111/liv.12434 10.1080/00365521.1984.12005842 10.1016/j.jhep.2011.10.025 10.14309/ajg.0000000000000290 10.1002/hep.1840110317 10.1016/j.jaut.2007.05.002 10.1006/jaut.1999.0299 10.1002/hep.1840130407 10.1016/j.dld.2018.11.008 |
| ContentType | Journal Article |
| Copyright | 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd |
| Copyright_xml | – notice: 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd – notice: 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. – notice: 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7U9 H94 K9. 7X8 |
| DOI | 10.1111/jgh.15329 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1440-1746 |
| EndPage | 1434 |
| ExternalDocumentID | 33141955 10_1111_jgh_15329 JGH15329 |
| Genre | article Meta-Analysis Systematic Review Journal Article |
| GeographicLocations | Asia North America Europe Pacific Islands Pacific region |
| GeographicLocations_xml | – name: Pacific Islands – name: Asia – name: Europe – name: North America – name: Pacific region |
| GrantInformation_xml | – fundername: Key Technical and Executive Measures to Improve Early Phase Clinical Tials on Innovative Drugs for Liver Diseases funderid: Z191100007619037 – fundername: National Key Technologies R&D Program for New Drug Development funderid: 2018ZX09201016 – fundername: National Science and Technology Major Project funderid: 2017ZX10203202003 – fundername: Key Technical and Executive Measures to Improve Early Phase Clinical Tials on Innovative Drugs for Liver Diseases grantid: Z191100007619037 – fundername: National Key Technologies R&D Program for New Drug Development grantid: 2018ZX09201016 – fundername: National Science and Technology Major Project grantid: 2017ZX10203202003 |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DTERQ DU5 EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KMS LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7T5 7U9 H94 K9. 7X8 |
| ID | FETCH-LOGICAL-c4199-b8533e8efcffda06cea4568c4b54cc260373a92c69217d26a56ee7143708ef7a3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 98 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000596100600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0815-9319 1440-1746 |
| IngestDate | Wed Oct 01 17:06:11 EDT 2025 Tue Oct 07 07:13:55 EDT 2025 Wed Feb 19 02:26:04 EST 2025 Tue Nov 18 21:43:06 EST 2025 Sat Nov 29 03:02:01 EST 2025 Wed Jan 22 16:28:33 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | meta-analysis epidemiology prevalence incidence primary biliary cholangitis |
| Language | English |
| License | 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4199-b8533e8efcffda06cea4568c4b54cc260373a92c69217d26a56ee7143708ef7a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-4673-8890 |
| PMID | 33141955 |
| PQID | 2539052850 |
| PQPubID | 2045136 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_2457653945 proquest_journals_2539052850 pubmed_primary_33141955 crossref_primary_10_1111_jgh_15329 crossref_citationtrail_10_1111_jgh_15329 wiley_primary_10_1111_jgh_15329_JGH15329 |
| PublicationCentury | 2000 |
| PublicationDate | June 2021 |
| PublicationDateYYYYMMDD | 2021-06-01 |
| PublicationDate_xml | – month: 06 year: 2021 text: June 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Australia |
| PublicationPlace_xml | – name: Australia – name: Richmond |
| PublicationTitle | Journal of gastroenterology and hepatology |
| PublicationTitleAlternate | J Gastroenterol Hepatol |
| PublicationYear | 2021 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2015; 184 1995; 30 2017; 8 1990; 11 2004; 127 1990; 12 2010; 59 2019; 51 2015; 149 1991; 13 2002; 97 1995; 36 2019; 13 1991; 96 1998; 118 2012; 56 1985; 20 2017; 186A 2014; 179 2007; 29 2018; 6 2019; 60 2003; 326 2014; 2 2009; 50 2019; 69 1999; 13 2016; 43 2019; 114 1984; 19 1996; 24 2012; 24 2012; 23 2010; 9 2007; 19 1990; 75 2019; 9 2009; 62 1997; 26 2019; 34 2000; 119 2017; 67 2005; 42 2018; 113A 2018; 22 2018; 68 2016; 6 1984; 4 2017; 15 2006; 43 2019 2019; 49 2005; 7 1999; 30 1980; 281 2020; 65 2007; 42 2012; 6 2001; 34 2012; 44 2014; 34 1998; 33 e_1_2_6_53_1 e_1_2_6_32_1 Shaheen AAM (e_1_2_6_49_1) 2018; 113 e_1_2_6_19_1 Chong VH (e_1_2_6_38_1) 2010; 9 e_1_2_6_59_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_17_1 e_1_2_6_55_1 e_1_2_6_15_1 e_1_2_6_57_1 e_1_2_6_62_1 Berdal JE (e_1_2_6_30_1) 1998; 118 e_1_2_6_64_1 e_1_2_6_43_1 e_1_2_6_20_1 e_1_2_6_41_1 e_1_2_6_60_1 e_1_2_6_9_1 Crooks CJ (e_1_2_6_42_1) 2014; 2 French J (e_1_2_6_52_1) 2019 e_1_2_6_5_1 e_1_2_6_7_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_22_1 Caballero Plasencia AM (e_1_2_6_26_1) 1991; 96 e_1_2_6_28_1 e_1_2_6_47_1 e_1_2_6_54_1 Webb G (e_1_2_6_65_1) 2017; 186 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_50_1 e_1_2_6_14_1 e_1_2_6_35_1 Delgado J (e_1_2_6_36_1) 2005; 7 e_1_2_6_12_1 e_1_2_6_33_1 e_1_2_6_18_1 e_1_2_6_39_1 e_1_2_6_56_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_58_1 e_1_2_6_63_1 e_1_2_6_21_1 Myszor M (e_1_2_6_13_1) 1990; 75 e_1_2_6_40_1 e_1_2_6_61_1 Lamba M (e_1_2_6_51_1) 2018; 68 e_1_2_6_8_1 e_1_2_6_4_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_48_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_29_1 e_1_2_6_44_1 Heetun Z (e_1_2_6_45_1) 2015; 184 e_1_2_6_27_1 e_1_2_6_46_1 35780017 - Hepatobiliary Pancreat Dis Int. 2022 Dec;21(6):597-599 |
| References_xml | – volume: 13 start-page: 650 year: 1991 end-page: 655 article-title: Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver publication-title: Hepatol. (Baltimore, Md) – volume: 127 start-page: 470 year: 2004 end-page: 475 article-title: Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations publication-title: Gastroenterology – volume: 34 start-page: 1236 year: 2019 end-page: 1241 article-title: Prognosis of 732 ursodeoxycholic acid‐treated patients with primary biliary cholangitis: a single center follow‐up study from China publication-title: J. Gastroenterol. Hepatol. – volume: 60 start-page: 494 year: 2019 end-page: 502 article-title: Epidemiological and clinical features of primary biliary cholangitis in two Croatian regions: a retrospective study publication-title: Croat. Med. J. – volume: 34 start-page: e200 year: 2014 end-page: e207 article-title: Geoepidemiology and space‐time analysis of primary biliary cirrhosis in Crete, Greece publication-title: Liver Int. Off. J. Int. Assoc. Study Liver – volume: 24 start-page: 813 year: 1996 end-page: 815 article-title: Clinical hepatology: profile of an urban, hospital‐based practice publication-title: Hepatol. (Baltimore, Md) – volume: 30 start-page: 390 year: 1999 end-page: 394 article-title: Primary biliary cirrhosis once rare, now common in the United Kingdom? publication-title: Hepatol. (Baltimore, Md) – volume: 36 start-page: 927 year: 1995 end-page: 930 article-title: Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group publication-title: Gut – volume: 75 start-page: 377 year: 1990 end-page: 385 article-title: The epidemiology of primary biliary cirrhosis in north‐east England: an increasingly common disease? publication-title: Q. J. Med. – volume: 15 start-page: 13 year: 2017 end-page: 18 article-title: Incidence of primary biliary cholangitis in a rural midwestern population publication-title: Clin. Med. Res. – volume: 56 start-page: 1181 year: 2012 end-page: 1188 article-title: Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review publication-title: J. Hepatol. – volume: 12 start-page: 98 year: 1990 end-page: 105 article-title: The demography of primary biliary cirrhosis in Ontario, Canada publication-title: Hepatol. (Baltimore, Md) – volume: 118 start-page: 4517 year: 1998 end-page: 4519 article-title: Incidence and prevalence of autoimmune liver diseases publication-title: Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke – volume: 23 start-page: e193 year: 2012 end-page: e198 article-title: Primary biliary cirrhosis in Southern Israel: a 20 year follow up study publication-title: Eur. J. Intern. Med. – volume: 149 start-page: 1804 year: 2015 end-page: 1812 article-title: Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy publication-title: Gastroenterology – volume: 179 start-page: 492 year: 2014 end-page: 498 article-title: No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England publication-title: Am. J. Epidemiol. – volume: 326 start-page: 219 year: 2003 end-page: 219 article-title: Statistics notes—interaction revisited: the difference between two estimates publication-title: BMJ‐Brit. Med. J. – volume: 43 start-page: 154 year: 2016 end-page: 162 article-title: Population‐based epidemiology of primary biliary cirrhosis in South Korea publication-title: Aliment. Pharmacol. Ther. – volume: 42 start-page: 1347 year: 2007 end-page: 1353 article-title: Prevalence and incidence of primary biliary cirrhosis are increasing in Finland publication-title: Scand. J. Gastroenterol. – volume: 13 start-page: 171 year: 1999 end-page: 178 article-title: Familial primary biliary cirrhosis in Hiroshima publication-title: J. Autoimmun. – volume: 42 start-page: 1194 year: 2005 end-page: 1202 article-title: Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview‐based study of 1032 patients publication-title: Hepatol. (Baltimore, Md) – volume: 59 start-page: 508 year: 2010 end-page: 512 article-title: Case‐control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations publication-title: Gut – volume: 51 start-page: 724 year: 2019 end-page: 729 article-title: Epidemiology of primary biliary cholangitis in Italy: evidence from a real‐world database publication-title: Dig. Liver Dis. – volume: 8 year: 2017 article-title: Epidemiology and natural history of primary biliary cholangitis in the Chinese: a territory‐based study in Hong Kong between 2000 and 2015 publication-title: Clin. Transl. Gastroenterol. – volume: 186A start-page: 66 year: 2017 article-title: Autoimmune liver disease in the UK: a national primary care evaluation of disease geoepidemiology publication-title: Hepatol. (Baltimore, Md) – volume: 13 start-page: 788 year: 2019 end-page: 799 article-title: Epidemiology and clinical course cholangitis in the Asia‐Pacific region: a systematic review and meta‐analysis publication-title: Hepatol. Int. – volume: 19 start-page: 971 year: 1984 end-page: 976 article-title: The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population publication-title: Scand. J. Gastroenterol. – volume: 24 start-page: 824 year: 2012 end-page: 830 article-title: The epidemiology and natural history of primary biliary cirrhosis: a nationwide population‐based study publication-title: Eur. J. Gastroenterol. Hepatol. – volume: 44 start-page: S38 year: 2012 article-title: Primary biliary cirrhosis in Lombardia: a lower than expected female‐to‐male incidence ratio with higher mortality in men publication-title: Dig. Liver Dis. – volume: 11 start-page: 458 year: 1990 end-page: 464 article-title: Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden publication-title: Hepatol. (Baltimore, Md) – volume: 26 start-page: 830 year: 1997 end-page: 836 article-title: Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England publication-title: Int. J. Epidemiol. – volume: 4 start-page: 195 year: 1984 end-page: 200 article-title: Epidemiology of primary biliary cirrhosis publication-title: Liver – volume: 6 start-page: E664 year: 2018 end-page: e670 article-title: Epidemiology and liver transplantation burden of primary biliary cholangitis: a retrospective cohort study publication-title: CMAJ Open – volume: 2 start-page: A54 year: 2014 article-title: Evidence of a north south gradient in the occurrence of primary biliary cirrhosis in the UK using two decades of national data publication-title: United Eur. Gastroenterol. J. – volume: 7 start-page: 717 year: 2005 end-page: 721 article-title: The epidemiology of primary biliary cirrhosis in southern Israel publication-title: Israel Med. Assoc. J. IMAJ – volume: 9 start-page: 622 year: 2010 end-page: 628 article-title: Primary biliary cirrhosis in Brunei Darussalam publication-title: Hepatobiliary Pancreat. Dis. Int. – volume: 19 start-page: 859 year: 2007 end-page: 864 article-title: Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community publication-title: Eur. J. Gastroenterol. Hepatol. – volume: 34 start-page: e31 year: 2014 end-page: e38 article-title: Rising incidence and prevalence of primary biliary cirrhosis: a large population‐based study publication-title: Liver Int. Off. J. Int. Assoc. Study Liver – volume: 97 start-page: 2402 year: 2002 end-page: 2407 article-title: Prevalence of autoimmune liver disease in Alaska Natives publication-title: Am. J. Gastroenterol. – volume: 49 start-page: 881 year: 2019 end-page: 889 article-title: Increase trend in the prevalence and male‐to‐female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan publication-title: Hepatol. Res. Off. J. Japan Soc. Hepatol. – volume: 34 start-page: 318 year: 2014 end-page: 328 article-title: The new epidemiology of primary biliary cirrhosis publication-title: Semin. Liver Dis. – volume: 30 start-page: 367 year: 1995 end-page: 371 article-title: Primary biliary cirrhosis in Estonia. With special reference to incidence, prevalence, clinical features, and outcome publication-title: Scand. J. Gastroenterol. – volume: 62 start-page: e1 year: 2009 end-page: e34 article-title: The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration publication-title: J. Clin. Epidemiol. – volume: 281 start-page: 772 year: 1980 end-page: 775 article-title: Primary biliary cirrhosis: an epidemiological study publication-title: Br. Med. J. – volume: 6 year: 2016 article-title: Evolving trends in female to male incidence and male mortality of primary biliary cholangitis publication-title: Sci. Rep. – volume: 65 start-page: 683 year: 2020 end-page: 691 article-title: Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia publication-title: Int. J. Public Health – volume: 69 start-page: 394 year: 2019 end-page: 419 article-title: Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases publication-title: Hepatol. (Baltimore, Md) – volume: 20 start-page: 647 year: 1985 end-page: 650 article-title: Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden publication-title: Scand. J. Gastroenterol. – volume: 34 start-page: 1083 year: 2001 end-page: 1088 article-title: The geographical distribution of primary biliary cirrhosis in a well‐defined cohort publication-title: Hepatol. (Baltimore, Md) – volume: 50 start-page: 1884 year: 2009 end-page: 1892 article-title: Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population‐based study publication-title: Hepatol. (Baltimore, Md) – volume: 113A start-page: 68 year: 2018 article-title: Canadian population‐based evaluation of the natural history of primary biliary cholangitis over the last decade publication-title: Hepatol. (Baltimore, Md) – volume: 67 start-page: 145 year: 2017 end-page: 172 article-title: EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis publication-title: J. Hepatol. – volume: 184 start-page: S94 year: 2015 article-title: Prevalence and epidemiology of autoimmune hepatitis and primary biliary cirrhosis across the South‐Eastern regional health board publication-title: Ir. J. Med. Sci. – volume: 6 start-page: 796 year: 2012 end-page: 800 article-title: Low incidence and prevalence of primary biliary cirrhosis in Canterbury, New Zealand: a population‐based study publication-title: Hepatol. Int. – volume: 22 start-page: 443 year: 2018 end-page: 455 article-title: The genetics and epigenetics of primary biliary cholangitis publication-title: Clin. Liver Dis. – volume: 33 start-page: 99 year: 1998 end-page: 103 article-title: Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population publication-title: Scand. J. Gastroenterol. – volume: 68 start-page: S231 year: 2018 article-title: Incidence of autoimmune hepatitis is increasing, while primary biliary cholangitis and primary sclerosing cholangitis have remain unchanged: a population‐based study publication-title: J. Hepatol. – volume: 114 start-page: 1101 year: 2019 end-page: 1108 article-title: Validation of risk scoring systems in ursodeoxycholic acid‐treated patients with primary biliary cholangitis publication-title: Am. J. Gastroenterol. – volume: 96 start-page: 481 year: 1991 end-page: 485 article-title: Epidemiology of primary biliary cirrhosis in the South area of Granada publication-title: Med. Clin. – volume: 43 start-page: 525 year: 2006 end-page: 531 article-title: Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites publication-title: Hepatol. (Baltimore, Md) – volume: 29 start-page: 1 year: 2007 end-page: 9 article-title: Epidemiology of autoimmune diseases in Denmark publication-title: J. Autoimmun. – year: 2019 article-title: Increasing prevalence of primary biliary cholangitis in Victoria, Australia publication-title: J. Gastroenterol. Hepatol. (Australia) – volume: 9 year: 2019 article-title: Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population‐based cohort publication-title: Sci. Rep. – volume: 119 start-page: 1631 year: 2000 end-page: 1636 article-title: Epidemiology and natural history of primary biliary cirrhosis in a US community publication-title: Gastroenterology – ident: e_1_2_6_39_1 doi: 10.1016/j.ejim.2012.09.004 – ident: e_1_2_6_48_1 doi: 10.3121/cmr.2017.1351 – ident: e_1_2_6_35_1 doi: 10.1053/j.gastro.2004.04.064 – ident: e_1_2_6_14_1 doi: 10.1111/j.1600-0676.1984.tb00927.x – ident: e_1_2_6_41_1 doi: 10.1007/s12072-011-9329-0 – ident: e_1_2_6_54_1 doi: 10.1111/hepr.13342 – ident: e_1_2_6_20_1 doi: 10.1136/bmj.326.7382.219 – ident: e_1_2_6_64_1 doi: 10.1055/s-0034-1383730 – volume: 2 start-page: A54 year: 2014 ident: e_1_2_6_42_1 article-title: Evidence of a north south gradient in the occurrence of primary biliary cirrhosis in the UK using two decades of national data publication-title: United Eur. Gastroenterol. J. – ident: e_1_2_6_16_1 doi: 10.1038/ctg.2017.43 – volume: 113 start-page: 68 year: 2018 ident: e_1_2_6_49_1 article-title: Canadian population‐based evaluation of the natural history of primary biliary cholangitis over the last decade publication-title: Hepatol. (Baltimore, Md) – ident: e_1_2_6_50_1 doi: 10.9778/cmajo.20180029 – ident: e_1_2_6_59_1 doi: 10.1053/jhep.2001.29760 – ident: e_1_2_6_57_1 doi: 10.1016/j.cld.2018.03.002 – ident: e_1_2_6_7_1 doi: 10.1038/s41598-019-47890-2 – ident: e_1_2_6_47_1 doi: 10.1111/apt.13448 – ident: e_1_2_6_29_1 doi: 10.1002/hep.510240410 – ident: e_1_2_6_18_1 doi: 10.3109/00365529509093292 – volume: 96 start-page: 481 year: 1991 ident: e_1_2_6_26_1 article-title: Epidemiology of primary biliary cirrhosis in the South area of Granada publication-title: Med. Clin. – ident: e_1_2_6_6_1 doi: 10.1007/s12072-019-09984-x – ident: e_1_2_6_55_1 doi: 10.1007/s00038-020-01391-6 – ident: e_1_2_6_10_1 doi: 10.1097/MEG.0b013e328277594a – ident: e_1_2_6_23_1 doi: 10.3109/00365528509089711 – ident: e_1_2_6_9_1 doi: 10.1002/hep.23210 – ident: e_1_2_6_15_1 doi: 10.3325/cmj.2019.60.494 – volume: 7 start-page: 717 year: 2005 ident: e_1_2_6_36_1 article-title: The epidemiology of primary biliary cirrhosis in southern Israel publication-title: Israel Med. Assoc. J. IMAJ – year: 2019 ident: e_1_2_6_52_1 article-title: Increasing prevalence of primary biliary cholangitis in Victoria, Australia publication-title: J. Gastroenterol. Hepatol. (Australia) – ident: e_1_2_6_56_1 doi: 10.1016/j.jhep.2017.03.022 – ident: e_1_2_6_17_1 doi: 10.1080/00365520701396034 – ident: e_1_2_6_21_1 doi: 10.1136/bmj.281.6243.772 – ident: e_1_2_6_58_1 doi: 10.1002/hep.21076 – ident: e_1_2_6_63_1 doi: 10.1136/gut.2009.184218 – ident: e_1_2_6_33_1 doi: 10.1053/gast.2000.20197 – volume: 9 start-page: 622 year: 2010 ident: e_1_2_6_38_1 article-title: Primary biliary cirrhosis in Brunei Darussalam publication-title: Hepatobiliary Pancreat. Dis. Int. – ident: e_1_2_6_31_1 doi: 10.1080/00365529850166284 – ident: e_1_2_6_19_1 doi: 10.1016/j.jclinepi.2009.06.006 – ident: e_1_2_6_40_1 doi: 10.1097/MEG.0b013e328353753d – ident: e_1_2_6_60_1 doi: 10.1111/jgh.14521 – volume: 118 start-page: 4517 year: 1998 ident: e_1_2_6_30_1 article-title: Incidence and prevalence of autoimmune liver diseases publication-title: Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke – ident: e_1_2_6_11_1 doi: 10.1002/hep.510300213 – ident: e_1_2_6_43_1 doi: 10.1111/liv.12479 – volume: 68 start-page: S231 year: 2018 ident: e_1_2_6_51_1 article-title: Incidence of autoimmune hepatitis is increasing, while primary biliary cholangitis and primary sclerosing cholangitis have remain unchanged: a population‐based study publication-title: J. Hepatol. doi: 10.1016/S0168-8278(18)30677-9 – ident: e_1_2_6_12_1 doi: 10.1093/ije/26.4.830 – ident: e_1_2_6_28_1 doi: 10.1136/gut.36.6.927 – ident: e_1_2_6_24_1 doi: 10.1002/hep.1840120116 – ident: e_1_2_6_62_1 doi: 10.1002/hep.20907 – ident: e_1_2_6_61_1 doi: 10.1016/S1590-8658(12)60110-8 – ident: e_1_2_6_34_1 doi: 10.1111/j.1572-0241.2002.06019.x – ident: e_1_2_6_46_1 doi: 10.1038/srep25906 – volume: 186 start-page: 66 year: 2017 ident: e_1_2_6_65_1 article-title: Autoimmune liver disease in the UK: a national primary care evaluation of disease geoepidemiology publication-title: Hepatol. (Baltimore, Md) – ident: e_1_2_6_3_1 doi: 10.1053/j.gastro.2015.07.061 – volume: 184 start-page: S94 year: 2015 ident: e_1_2_6_45_1 article-title: Prevalence and epidemiology of autoimmune hepatitis and primary biliary cirrhosis across the South‐Eastern regional health board publication-title: Ir. J. Med. Sci. – volume: 75 start-page: 377 year: 1990 ident: e_1_2_6_13_1 article-title: The epidemiology of primary biliary cirrhosis in north‐east England: an increasingly common disease? publication-title: Q. J. Med. – ident: e_1_2_6_44_1 doi: 10.1093/aje/kwt308 – ident: e_1_2_6_2_1 doi: 10.1002/hep.30145 – ident: e_1_2_6_8_1 doi: 10.1111/liv.12434 – ident: e_1_2_6_22_1 doi: 10.1080/00365521.1984.12005842 – ident: e_1_2_6_5_1 doi: 10.1016/j.jhep.2011.10.025 – ident: e_1_2_6_4_1 doi: 10.14309/ajg.0000000000000290 – ident: e_1_2_6_25_1 doi: 10.1002/hep.1840110317 – ident: e_1_2_6_37_1 doi: 10.1016/j.jaut.2007.05.002 – ident: e_1_2_6_32_1 doi: 10.1006/jaut.1999.0299 – ident: e_1_2_6_27_1 doi: 10.1002/hep.1840130407 – ident: e_1_2_6_53_1 doi: 10.1016/j.dld.2018.11.008 – reference: 35780017 - Hepatobiliary Pancreat Dis Int. 2022 Dec;21(6):597-599 |
| SSID | ssj0004075 |
| Score | 2.6002715 |
| SecondaryResourceType | review_article |
| Snippet | Background and Aim
We aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends.
Methods
Studies... We aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends. Studies on epidemiology of primary... Background and AimWe aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends.MethodsStudies on... We aimed to estimate the worldwide incidence and prevalence, with focus on the geographical differences and temporal trends.BACKGROUND AND AIMWe aimed to... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1423 |
| SubjectTerms | Asia - epidemiology Cholangitis Epidemiology Europe - epidemiology Female Global Health - statistics & numerical data Global Health - trends Humans Incidence Liver Cirrhosis, Biliary - epidemiology Male Meta-analysis North America - epidemiology Pacific Islands - epidemiology Population studies Prevalence primary biliary cholangitis Sensitivity analysis |
| Title | Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta‐analysis |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjgh.15329 https://www.ncbi.nlm.nih.gov/pubmed/33141955 https://www.proquest.com/docview/2539052850 https://www.proquest.com/docview/2457653945 |
| Volume | 36 |
| WOSCitedRecordID | wos000596100600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1440-1746 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004075 issn: 0815-9319 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fa9swED_SZJS-7E_Xdtm6oJU95MXDtiTb2p7KtjSMLJSwQN6MLMvpIHNGkhbWp36EfcZ-kp5kxVnoBoM-2aCTZHR3vjvp9DuAtxxtIDqegZcUHAOUTMVeRlXkRVxngklW8NxC5g_i4TCZTMR5Az6s78JU-BD1hpvRDPu_Ngous-WfSj69eIfqGoodaIUot7wJrU-j3niwuRZZ4eyi0eOeQFFzwEI2kWfdedsc3fMxt11Wa3N6Tx70tU_hsXM1yWklG8-goct92P3qDtOfw_VIT-1GILnCgNlyiMgyJw6takZWJl-WzAvys4KkICaR1jxtQGwKHX1fEr0pMfvrPTklG2hoUl2LsWP-0Ct5e_NbOgiUAxj3Pn_72PdcKQZPsUAIL0OrTnWiC1UUufQjpSV6XoliGWdKYUxEYypFqCKBIU4eRpJHWpvS6rGPnWJJD6FZzkv9Akgc0yIvMpFTHIOivyKjIElY5qsgDxmlbeiuOZIqh1NuymXM0jpemV6kdi3bcFKTupX4G9Hxmq2p089lGnIqfB4m3G_Dm7oZNcscl8hSzy-RhmEshnSMt-GoEod6FkoDXBeOLV3L9X9Pn34569uXl_9P-gr2QpM6Yzd7jqG5Wlzq1_BIXSFbFx3YiSdJxwn7HdlcAqk |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7xEnBpC7SwLQ-DOHAJSmI7iateUNtlgWWFEEjcIsdxdpEgi2BBghM_ob-xv6Rjx5sFARJST4nksR15ZjIP298AbHK0geh4Bl5ScAxQMhV7GVWRF3GdCSZZwXMLmd-OO53k7EwcjcGP4V2YCh-iTrgZzbD_a6PgJiH9VMu7vW3U11CMwyRDMUL5nvx13Dxtj-5FVkC7aPW4J1DWHLKQPckz7PzcHr1wMp_7rNboND_-3-d-gg_O2SQ7lXTMwZgu52H60G2nL8DDse7aVCC5w5DZ8ojIMicOr-qCDMyJWdIvyFUFSkHMUVrztCGxKXV0fkP0qMjs_XeyQ0bg0KS6GGPHvNQD-ffxj3QgKJ_htPn75GfLc8UYPMUCIbwM7TrViS5UUeTSj5SW6HslimWcKYVREY2pFKGKBAY5eRhJHmltiqvHPnaKJf0CE2W_1EtA4pgWeZGJnOIYFD0WGQVJwjJfBXnIKG3A1pAlqXJI5aZgxkVaRyzdXmrXsgEbNalbideIlod8TZ2G3qQhp8LnYcL9BqzXzahbZsNElrp_izQMozGkY7wBi5U81LNQGuC6cGzZsmx_e_p0f7dlX76-n3QNZlonh-20vdc5-AazoTlIY1M_yzAxuL7VKzCl7pDF16tO5v8BM6MFsQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTtwwEB7RpUK9UGhLWX6KQRy4BCWxncSIC4JuoV1WCBWJW-Q49oIEWQQLEpx4hD5jn6Rjx5sFlUqVOCWSx3bkmcnM2ONvANY52kB0PKMgMxwDlEKlQUFVEiRcF4JJZnjpIPO7aa-XnZ6KownYHt2FqfEhmg03qxnuf20VXF-V5qmW9882UV9j8QYmmS0i04LJvePOSXd8L7IG2kWrxwOBsuaRhVwmz6jzc3v0l5P53Gd1Rqfz_nWfOwPT3tkkO7V0zMKErj7A1KE_Tv8ID8e677YCyR2GzI5HRFYl8XhVF2RoM2bJwJCrGpSC2FRa-3QhsS11dH5D9LjI7P0W2SFjcGhSX4xxY17qofz9-Et6EJRPcNL5-nN3P_DFGALFIiGCAu061Zk2yphShonSEn2vTLGCM6UwKqIplSJWicAgp4wTyROtbXH1NMROqaRz0KoGlZ4HkqbUlKYQJcUxKHosMomyjBWhisqYUdqGjRFLcuWRym3BjIu8iVj6Z7lbyzasNaR-JV4iWhrxNfcaepPHnIqQxxkP27DaNKNu2QMTWenBLdIwjMaQjvE2fK7loZmF0gjXhWPLhmP7v6fPv3_bdy8L_0-6AlNHe528e9D7sQjvYptH43Z-lqA1vL7Vy_BW3SGHr794kf8Dt1sFLA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Regional+variation+and+temporal+trend+of+primary+biliary+cholangitis+epidemiology%3A+A+systematic+review+and+meta%E2%80%90analysis&rft.jtitle=Journal+of+gastroenterology+and+hepatology&rft.au=Lv%2C+Tingting&rft.au=Chen%2C+Sha&rft.au=Li%2C+Min&rft.au=Zhang%2C+Dong&rft.date=2021-06-01&rft.issn=0815-9319&rft.eissn=1440-1746&rft.volume=36&rft.issue=6&rft.spage=1423&rft.epage=1434&rft_id=info:doi/10.1111%2Fjgh.15329&rft.externalDBID=10.1111%252Fjgh.15329&rft.externalDocID=JGH15329 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0815-9319&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0815-9319&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0815-9319&client=summon |